We could not find any results for:
Make sure your spelling is correct or try broadening your search.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX... RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues. Show more
- Confirmed objective response rate (ORR) of 15.6% in all patients regardless of PD-L1 or HPV status - Confirmed ORR of 17.4% in subset of patients with PD-L1+ disease - Confirmed ORR of 22.2...
SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing...
SOUTH SAN FRANCISCO, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage, immunology-based therapeutics company focused on discovering, developing...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.62 | -7.31132075472 | 8.48 | 8.5699 | 7.62 | 765378 | 8.01248419 | CS |
4 | -0.52 | -6.20525059666 | 8.38 | 9.6536 | 7.62 | 838930 | 8.52069398 | CS |
12 | -18.18 | -69.8156682028 | 26.04 | 27.35 | 6.86 | 1428042 | 9.7750133 | CS |
26 | -3.44 | -30.4424778761 | 11.3 | 27.35 | 6.86 | 896079 | 12.08146345 | CS |
52 | -11.83 | -60.0812595226 | 19.69 | 27.35 | 6.86 | 599380 | 13.88625399 | CS |
156 | -14.01 | -64.0603566529 | 21.87 | 43.26 | 6.86 | 477572 | 21.76189966 | CS |
260 | -4.39 | -35.8367346939 | 12.25 | 51.2095 | 6.86 | 380380 | 22.09607324 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions